These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31914533)

  • 21. Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin Lymphomas.
    Moore EM; Swerdlow SH; Gibson SE
    Am J Surg Pathol; 2018 Mar; 42(3):342-350. PubMed ID: 29309299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
    Moore EM; Swerdlow SH; Gibson SE
    Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunohistochemical patterns of follicular dendritic cell meshwork and Ki-67 in small B-cell lymphomas].
    Shi YF; Li XH
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):222-6. PubMed ID: 23928527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Highly sensitive and specific
    Federmann B; Frauenfeld L; Pertsch H; Borgmann V; Steinhilber J; Bonzheim I; Fend F; Quintanilla-Martinez L
    Haematologica; 2020 Mar; 105(3):754-764. PubMed ID: 31296581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased tumour angiogenesis in SOX11-positive mantle cell lymphoma.
    Petrakis G; Veloza L; Clot G; Gine E; Gonzalez-Farre B; Navarro A; Bea S; Martínez A; Lopez-Guillermo A; Amador V; Ribera-Cortada I; Campo E
    Histopathology; 2019 Nov; 75(5):704-714. PubMed ID: 31173643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of SOX11 expression in routine lymphoma tissue sections: characterization of new monoclonal antibodies for diagnosis of mantle cell lymphoma.
    Soldini D; Valera A; Solé C; Palomero J; Amador V; Martin-Subero JI; Ribera-Cortada I; Royo C; Salaverria I; Beà S; Gonzalvo E; Johannesson H; Herrera M; Colomo L; Martinez A; Campo E
    Am J Surg Pathol; 2014 Jan; 38(1):86-93. PubMed ID: 24145648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinicopathologic features and prognosis of gastrointestinal mantle cell lymphoma].
    Hou WH; Wei P; Xie JL; Zheng YY; Zhang YL; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2018 Oct; 47(10):763-768. PubMed ID: 30317731
    [No Abstract]   [Full Text] [Related]  

  • 28. Pattern of MEF2B expression in lymphoid tissues and in malignant lymphomas.
    Krenács D; Borbényi Z; Bedekovics J; Méhes G; Bagdi E; Krenács L
    Virchows Arch; 2015 Sep; 467(3):345-55. PubMed ID: 26089142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SOXC and MiR17-92 gene expression profiling defines two subgroups with different clinical outcome in mantle cell lymphoma.
    Roisman A; Huamán Garaicoa F; Metrebian F; Narbaitz M; Kohan D; García Rivello H; Fernandez I; Pavlovsky A; Pavlovsky M; Hernández L; Slavutsky I
    Genes Chromosomes Cancer; 2016 Jun; 55(6):531-40. PubMed ID: 26998831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression profiling and chromatin immunoprecipitation identify DBN1, SETMAR and HIG2 as direct targets of SOX11 in mantle cell lymphoma.
    Wang X; Björklund S; Wasik AM; Grandien A; Andersson P; Kimby E; Dahlman-Wright K; Zhao C; Christensson B; Sander B
    PLoS One; 2010 Nov; 5(11):e14085. PubMed ID: 21124928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reproducibility of SOX-11 detection in decalcified bone marrow tissue in mantle cell lymphoma patients.
    Righi S; Pileri S; Agostinelli C; Bacci F; Spagnolo S; Sabattini E
    Hum Pathol; 2017 Jan; 59():94-101. PubMed ID: 27720733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-132-3p serves as a tumor suppressor in mantle cell lymphoma via directly targeting SOX11.
    Wu B; Li J; Wang H; Wu Q; Liu H
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2197-2208. PubMed ID: 32040593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of SOX11 and Genetic Events Cooperating with Cyclin D1 in Mantle Cell Lymphoma.
    Beà S; Amador V
    Curr Oncol Rep; 2017 Jun; 19(6):43. PubMed ID: 28466437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Classical type and blastoid variant mantle cell lymphoma in the same lymph node: Histology and cytological findings from a touch imprint specimen.
    Nakatsuka SI; Nagatomo T; Nagano T; Goto T; Hashimoto K
    Diagn Cytopathol; 2017 Apr; 45(4):364-370. PubMed ID: 28140514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemistry for LEF1 and SOX11 adds diagnostic specificity in small B-cell lymphomas.
    Rangan A; Reinig E; McPhail ED; Rech KL
    Hum Pathol; 2022 Mar; 121():29-35. PubMed ID: 35066013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of SOX11 transcription factor. Its implication in mantle cell lymphoma].
    Roisman A; Slavutsky I
    Medicina (B Aires); 2014; 74(2):140-6. PubMed ID: 24736261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SOX11 expression in mantle cell lymphoma.
    Xu W; Li JY
    Leuk Lymphoma; 2010 Nov; 51(11):1962-7. PubMed ID: 20919851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of p53, Sox11, and Pax5 co-expression in mantle cell lymphoma.
    Jing C; Zheng Y; Feng Y; Cao X; Xu C
    Sci Rep; 2021 Jun; 11(1):11896. PubMed ID: 34099776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A highly sensitive and specific qPCR assay for quantification of the biomarker SOX11 in mantle cell lymphoma.
    Hamborg KH; Bentzen HH; Grubach L; Hokland P; Nyvold CG
    Eur J Haematol; 2012 Nov; 89(5):385-94. PubMed ID: 22827557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumorigenic role of Musashi-2 in aggressive mantle cell lymphoma.
    Sureda-Gómez M; Balsas P; Rodríguez ML; Nadeu F; De Bolòs A; Eguileor Á; Kulis M; Castellano G; López C; Giné E; Demajo S; Jares P; Martín-Subero JI; Beà S; Campo E; Amador V
    Leukemia; 2023 Feb; 37(2):408-421. PubMed ID: 36509891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.